We are live on ! Find out more
GC

Grimes & Company Portfolio holdings

AUM $4.62B
1-Year Est. Return 29.71%
This Fund
S&P 500
This Quarter Est. Return
+3.74%
1 Year Est. Return
+29.71%
3 Year Est. Return
+66.17%
5 Year Est. Return
+73.59%
10 Year Est. Return
+287.63%
AUM
$2.82B
AUM Growth
+$380M
Cap. Flow
+$289M
Cap. Flow %
10.23%
Top 10 Hldgs %
47.61%
Holding
326
New
24
Increased
122
Reduced
122
Closed
11

Sector Composition

Rank Sector Weight
1 Technology 12.49%
2 Healthcare 6.65%
3 Financials 4.76%
4 Industrials 4.1%
5 Consumer Discretionary 2.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RTX icon
26
RTX Corp
RTX
$289B
$20.1M 0.71%
204,775
+1,858
+0.9% +$182K
SCHW
27
Charles Schwab
SCHW
$181B
$19.1M 0.68%
336,272
+17,674
+6% +$926K
ACN icon
28
Accenture
ACN
$99.9B
$18.8M 0.67%
60,803
+132
+0.2% +$38.4K
UPS icon
29
United Parcel Service
UPS
$89.5B
$18.8M 0.67%
104,618
+1,528
+1% +$271K
XLY icon
30
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$21.9B
$18.4M 0.65%
+216,482
New +$16.6M
TROW icon
31
T. Rowe Price
TROW
$25.6B
$18M 0.64%
161,096
+2,249
+1% +$246K
XLC icon
32
State Street Communication Services Select Sector SPDR ETF
XLC
$21.9B
$17.9M 0.64%
275,162
-358,473
-57% -$21.8M
XLF icon
33
State Street Financial Select Sector SPDR ETF
XLF
$56.8B
$17.9M 0.63%
+530,022
New +$17.3M
META icon
34
Meta Platforms (Facebook)
META
$1.37T
$17.6M 0.62%
61,271
-12,206
-17% -$3.01M
AMZN icon
35
Amazon
AMZN
$2.53T
$17.6M 0.62%
134,831
+993
+0.7% +$113K
EMR icon
36
Emerson Electric
EMR
$83.3B
$17.4M 0.62%
192,669
+3,003
+2% +$253K
RF icon
37
Regions Financial
RF
$26.3B
$17.4M 0.62%
977,028
+37,098
+4% +$655K
CVS icon
38
CVS Health
CVS
$134B
$16.7M 0.59%
240,940
+34,293
+17% +$2.44M
INTC icon
39
Intel
INTC
$460B
$16.1M 0.57%
480,572
-12,743
-3% -$400K
AMD icon
40
Advanced Micro Devices
AMD
$791B
$15.4M 0.55%
135,272
-1,966
-1% -$204K
RHI icon
41
Robert Half
RHI
$3.81B
$15.4M 0.55%
204,386
+17,255
+9% +$1.23M
JNJ icon
42
Johnson & Johnson
JNJ
$617B
$15.4M 0.54%
92,825
-1,886
-2% -$304K
MDT icon
43
Medtronic
MDT
$110B
$15.3M 0.54%
173,451
+3,206
+2% +$276K
V icon
44
Visa
V
$684B
$15M 0.53%
63,067
-35
-0.1% -$8.01K
ADBE icon
45
Adobe
ADBE
$98.5B
$14.7M 0.52%
30,158
-5,125
-15% -$2.06M
QCOM icon
46
Qualcomm
QCOM
$159B
$14.4M 0.51%
121,096
-1,090
-0.9% -$125K
EOG icon
47
EOG Resources
EOG
$77.5B
$14.3M 0.51%
124,799
+16,172
+15% +$1.85M
AMAT icon
48
Applied Materials
AMAT
$398B
$13.7M 0.49%
94,832
+1,196
+1% +$150K
JPM icon
49
JPMorgan Chase
JPM
$933B
$12.9M 0.46%
88,773
+1,131
+1% +$156K
ABBV icon
50
AbbVie
ABBV
$455B
$12.8M 0.46%
95,295
+688
+0.7% +$101K

Similar funds

Grimes & Company's Q2 2023 Portfolio in Review

As of Q2 2023, Grimes & Company held 326 positions worth $2.82B, up 16% from $2.44B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Grimes & Company deployed $289M of net new capital in Q2 2023, opening 24 new positions and adding to 122 existing holdings. Its largest new stake was LHA Risk-Managed Income ETF: 1,188,814 shares worth $29.9M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was State Street Communication Services Select Sector SPDR ETF, an estimated $21.8M trimmed.

  • Grimes & Company's largest Q2 2023 buy was LHA Risk-Managed Income ETF: 1,188,814 shares worth $29.9M.
  • Grimes & Company added most to iShares Russell 2000 ETF in Q2 2023, an estimated $160M increase.
  • Grimes & Company's biggest Q2 2023 reduction was State Street Communication Services Select Sector SPDR ETF, cutting an estimated $21.8M.
  • Grimes & Company fully exited State Street Materials Select Sector SPDR ETF in Q2 2023, selling an estimated $17M.
  • Grimes & Company's ten largest holdings make up 48% of its $2.82B portfolio in Q2 2023.
  • Grimes & Company opened 24 new positions and closed 11 in Q2 2023.
  • Grimes & Company's portfolio value rose 16% quarter-over-quarter to $2.82B.

Based on Grimes & Company's 13F filing for Q2 2023, filed 19 Jul 2023.